Table 2. Incidence of common adverse events associated with the two dose regimens of gefitinib.
Types of adverse events | H group (n = 48) | S group (n = 48) | P value | |||
---|---|---|---|---|---|---|
All Grade | Grade 3-4 | All Grade | Grade 3-4 | All Grade | Grade 3-4 | |
Acne-like rash, n (%) | 41 (85.4%) | 7 (14.6%)* | 33 (68.8%) | 0 | 0.567 | 0.012* |
Diarrhea, n (%) | 8 (16.7%) | 0 | 6 (12.5%) | 0 | 0.577 | NA |
Abnormal aminotransferases level, n (%) | 3 (6.3%) | 0 | 1 (2.1%) | 0 | 0.242* | NA |
*Fisher exact test.
H groups refers to escalated gefitinib (500 mg/d), while S group refers to standard dose gefitinib (250 mg/d). NA, not applicable.